阿科酵母®气泡

Arkolevure®啤酒酵母

Arkolevure®是一种共生酵母,结合了保证活性成分的酿酒酵母(Saccharomyces boulardii)和菊粉,这是一种促进包括酵母在内的益生酵素发展的益生元。该产品治疗和预防服用抗生素引起的腹泻的疗效已得到公认。


其创新的制造技术和超保护泡罩包装确保了最佳的存储条件。

13位条形码:3401560165883-10粒装
13位条形码:34015460165890-20粒装

膳食补充剂.

  • 3-6岁儿童 : 每天1粒,打开胶囊将内容物与食物混合(甜点慕斯,果泥,奶制品甜点……).
  • 成人和7岁以上儿童 : 每天1粒,随餐用大杯水吞服.

注意事项

  • 膳食补充剂不能替代平衡、多样的饮食以及健康的生活方式.
  • 勿超过每日建议用量.
  • 请置于儿童不能触及的地方.
  • 哺乳期及孕中期妇女可以服用.
  • 25摄氏度以下环境储存.

D’Souza, A. L., Rajkumar, C., Cooke, J. & Bulpitt, C. J. Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ 324, 1361 (2002).

Szajewska, H. & Kołodziej, M. Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Aliment. Pharmacol. Ther. 42, 793–801 (2015).

Kotowska, M., Albrecht, P. & Szajewska, H. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial. Alimentary Pharmacology & Therapeutics 21, 583–590 (2005).

Erdeve, O., Tiras, U. & Dallar, Y. The probiotic effect of Saccharomyces boulardii in a pediatric age group. J. Trop. Pediatr. 50, 234–236 (2004).

Shan, L.-S. et al. Prevention and treatment of diarrhoea with Saccharomyces boulardii in children with acute lower respiratory tract infections. Benef Microbes 4, 329–334 (2013).

McFarland, L. V. et al. Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. Am. J. Gastroenterol. 90, 439–448 (1995).

Surawicz, C. M. et al. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology 96, 981–988 (1989).

Hurduc, V., Plesca, D., Dragomir, D., Sajin, M. & Vandenplas, Y. A randomized, open trial evaluating the effect of Saccharomyces boulardii on the eradication rate of Helicobacter pylori infection in children. Acta Paediatr. 98, 127–131 (2009).

Szajewska, H., Horvath, A. & Kołodziej, M. Systematic review with meta-analysis: Saccharomyces boulardii supplementation and eradication of Helicobacter pylori infection. Aliment. Pharmacol. Ther. 41, 1237–1245 (2015).

McFarland, L. V. Meta-analysis of probiotics for the prevention of traveler’s diarrhea. Travel Medicine and Infectious Disease 5, 97–105 (2007).

Kelesidis, T. & Pothoulakis, C. Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders. Therap Adv Gastroenterol 5, 111–125 (2012).

Kollaritsch, H., Kremsner, P., Wiedermann, G. & Scheiner, O. Prevention of traveller’s diarrhea: comparison of different non-antibiotic preparations. Travel Med Int 11, 9–17 (1989).

Feizizadeh, S., Salehi-Abargouei, A. & Akbari, V. Efficacy and safety of Saccharomyces boulardii for acute diarrhea. Pediatrics 134, e176–191 (2014).

Mansour-Ghanaei, F., Dehbashi, N., Yazdanparast, K. & Shafaghi, A. Efficacy of saccharomyces boulardii with antibiotics in acute amoebiasis. World J. Gastroenterol. 9, 1832–1833 (2003).

    Arkolevure®酵母承诺:保证高品质和剂量

    啤酒酵母菌是一种非常脆弱的活微生物,其活性受氧气、光照、湿度、高温和时间影响,它的保存方法对于保证质量至关重要.

    Arkolevure®啤酒酵母胶囊在受控气氛条件下进行,采用100%不透明和超耐磨铝合金双层超防护泡罩包装,确保了产品在保质期内含酵母剂量超过25亿*。这意味着每粒胶囊可为您带来超过25亿菌落形成单位*的活性酵母.

    Arkolevure®以植物胶囊包装,其特殊配方,不添加乳糖,不添加糖和色素,为您提供最佳品质的产品。


    成分详情

    酵母粉** 啤酒酵母菌 - 菊粉。植物胶囊:羟丙基甲基纤维素.


    营养成分表 

      1粒胶囊
    啤酒酵母 (25亿菌落行程单位 *) 250 mg
    菊粉 60 mg
    * 正常储存条件下和有效期限内可保证的菌落形成单位(CFU).
    ** 活性酵母.

      Arkolevure®酵母承诺:保证高品质和剂量

      啤酒酵母菌是一种非常脆弱的活微生物,其活性受氧气、光照、湿度、高温和时间影响,它的保存方法对于保证质量至关重要.

      Arkolevure®啤酒酵母胶囊在受控气氛条件下进行,采用100%不透明和超耐磨铝合金双层超防护泡罩包装,确保了产品在保质期内含酵母剂量超过25亿*。这意味着每粒胶囊可为您带来超过25亿菌落形成单位*的活性酵母.

      Arkolevure®以植物胶囊包装,其特殊配方,不添加乳糖,不添加糖和色素,为您提供最佳品质的产品。


      成分详情

      酵母粉** 啤酒酵母菌 - 菊粉。植物胶囊:羟丙基甲基纤维素.


      营养成分表 

        1粒胶囊
      啤酒酵母 (25亿菌落行程单位 *) 250 mg
      菊粉 60 mg
      * 正常储存条件下和有效期限内可保证的菌落形成单位(CFU).
      ** 活性酵母.

      膳食补充剂.

      • 3-6岁儿童 : 每天1粒,打开胶囊将内容物与食物混合(甜点慕斯,果泥,奶制品甜点……).
      • 成人和7岁以上儿童 : 每天1粒,随餐用大杯水吞服.

      注意事项

      • 膳食补充剂不能替代平衡、多样的饮食以及健康的生活方式.
      • 勿超过每日建议用量.
      • 请置于儿童不能触及的地方.
      • 哺乳期及孕中期妇女可以服用.
      • 25摄氏度以下环境储存.

      D’Souza, A. L., Rajkumar, C., Cooke, J. & Bulpitt, C. J. Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ 324, 1361 (2002).

      Szajewska, H. & Kołodziej, M. Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Aliment. Pharmacol. Ther. 42, 793–801 (2015).

      Kotowska, M., Albrecht, P. & Szajewska, H. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial. Alimentary Pharmacology & Therapeutics 21, 583–590 (2005).

      Erdeve, O., Tiras, U. & Dallar, Y. The probiotic effect of Saccharomyces boulardii in a pediatric age group. J. Trop. Pediatr. 50, 234–236 (2004).

      Shan, L.-S. et al. Prevention and treatment of diarrhoea with Saccharomyces boulardii in children with acute lower respiratory tract infections. Benef Microbes 4, 329–334 (2013).

      McFarland, L. V. et al. Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. Am. J. Gastroenterol. 90, 439–448 (1995).

      Surawicz, C. M. et al. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology 96, 981–988 (1989).

      Hurduc, V., Plesca, D., Dragomir, D., Sajin, M. & Vandenplas, Y. A randomized, open trial evaluating the effect of Saccharomyces boulardii on the eradication rate of Helicobacter pylori infection in children. Acta Paediatr. 98, 127–131 (2009).

      Szajewska, H., Horvath, A. & Kołodziej, M. Systematic review with meta-analysis: Saccharomyces boulardii supplementation and eradication of Helicobacter pylori infection. Aliment. Pharmacol. Ther. 41, 1237–1245 (2015).

      McFarland, L. V. Meta-analysis of probiotics for the prevention of traveler’s diarrhea. Travel Medicine and Infectious Disease 5, 97–105 (2007).

      Kelesidis, T. & Pothoulakis, C. Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders. Therap Adv Gastroenterol 5, 111–125 (2012).

      Kollaritsch, H., Kremsner, P., Wiedermann, G. & Scheiner, O. Prevention of traveller’s diarrhea: comparison of different non-antibiotic preparations. Travel Med Int 11, 9–17 (1989).

      Feizizadeh, S., Salehi-Abargouei, A. & Akbari, V. Efficacy and safety of Saccharomyces boulardii for acute diarrhea. Pediatrics 134, e176–191 (2014).

      Mansour-Ghanaei, F., Dehbashi, N., Yazdanparast, K. & Shafaghi, A. Efficacy of saccharomyces boulardii with antibiotics in acute amoebiasis. World J. Gastroenterol. 9, 1832–1833 (2003).